Eupraxia (EPRX) analyst forecast and price target
Analyst forecast
Consensus of 11 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Oppenheimer | Initiated Coverage | Outperform | $17.00 | Jun 26, 2026 |
| Stifel | Initiated Coverage | Buy | $25.00 | May 21, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | May 4, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Apr 22, 2026 |
| William Blair | Initiated Coverage | Outperform | — | Mar 23, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 from $12.00 | Mar 17, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $19.00 from $11.00 | Jan 15, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Jan 9, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Aug 20, 2025 |
| Cantor Fitzgerald | Initiated Coverage | Overweight | $11.00 | Jul 24, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $12.00 | Jun 26, 2025 |
| Canaccord Genuity | Initiated Coverage | Speculative Buy | $9.00 | Jun 16, 2025 |
| Rodman & Renshaw | Initiated Coverage | Buy | $9.00 | Nov 14, 2024 |
Frequently asked questions
Is EPRX a buy, sell, or hold?
Analysts covering Eupraxia currently average a Buy rating: 11 buy, 0 hold and 0 sell, from 11 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on EPRX?
On Jun 26, 2026, Oppenheimer initiated coverage of Eupraxia at Outperform with a price target of $17.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.